PD Dr. Daniel Merk

Welcome

Research in our group addresses nuclear receptors as (potential) drug targets. These proteins act as ligand-activated transcription factors and translate small molecule ligand signals into adaptions in gene expression. We study the medicinal chemistry of nuclear receptor ligands and develop nuclear receptor modulators as tool compounds. Therein, we focus on nuclear receptors involved in neuro-protection and neurodegeneration.


Group

People

Welcome

Research

Nuclear receptor ligand discovery, design and optimization


Publications

Publications

Please use the following link for a complete list of publications:

more info

Open positions

Open positions

Coming soon